Fortitude Family Office LLC Acquires 32 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Fortitude Family Office LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 40.0% in the third quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 112 shares of the medical equipment provider’s stock after purchasing an additional 32 shares during the period. Fortitude Family Office LLC’s holdings in Intuitive Surgical were worth $55,000 as of its most recent SEC filing.

Several other large investors have also recently made changes to their positions in the business. China Universal Asset Management Co. Ltd. increased its position in Intuitive Surgical by 34.2% during the 3rd quarter. China Universal Asset Management Co. Ltd. now owns 9,318 shares of the medical equipment provider’s stock valued at $4,578,000 after buying an additional 2,374 shares in the last quarter. Traynor Capital Management Inc. grew its stake in shares of Intuitive Surgical by 80.0% in the third quarter. Traynor Capital Management Inc. now owns 36,363 shares of the medical equipment provider’s stock worth $17,864,000 after acquiring an additional 16,161 shares during the last quarter. abrdn plc increased its holdings in shares of Intuitive Surgical by 1.7% during the third quarter. abrdn plc now owns 250,794 shares of the medical equipment provider’s stock valued at $122,498,000 after acquiring an additional 4,240 shares in the last quarter. Pallas Capital Advisors LLC raised its position in shares of Intuitive Surgical by 4.6% in the 3rd quarter. Pallas Capital Advisors LLC now owns 1,626 shares of the medical equipment provider’s stock worth $832,000 after purchasing an additional 71 shares during the last quarter. Finally, Orrstown Financial Services Inc. bought a new position in Intuitive Surgical in the 3rd quarter worth about $258,000. 83.64% of the stock is currently owned by hedge funds and other institutional investors.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the sale, the executive vice president now owns 7,066 shares in the company, valued at $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this hyperlink. In other Intuitive Surgical news, EVP Brian Edward Miller sold 2,553 shares of the company’s stock in a transaction that occurred on Tuesday, October 22nd. The shares were sold at an average price of $515.00, for a total value of $1,314,795.00. Following the completion of the transaction, the executive vice president now directly owns 7,066 shares in the company, valued at $3,638,990. This represents a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, Director Amal M. Johnson sold 2,943 shares of the stock in a transaction on Thursday, August 1st. The stock was sold at an average price of $443.30, for a total transaction of $1,304,631.90. Following the completion of the sale, the director now directly owns 12,275 shares of the company’s stock, valued at approximately $5,441,507.50. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 53,038 shares of company stock worth $25,857,344. Corporate insiders own 0.80% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of research firms have weighed in on ISRG. Piper Sandler restated an “overweight” rating and set a $538.00 price objective (up from $495.00) on shares of Intuitive Surgical in a research note on Friday, October 18th. Morgan Stanley boosted their price objective on shares of Intuitive Surgical from $375.00 to $460.00 and gave the stock an “equal weight” rating in a report on Monday, July 15th. Wells Fargo & Company increased their target price on Intuitive Surgical from $466.00 to $549.00 and gave the company an “overweight” rating in a research note on Friday, October 18th. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the stock an “overweight” rating in a research note on Friday, October 11th. Finally, Citigroup upped their price target on Intuitive Surgical from $512.00 to $560.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fourteen have issued a buy rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $513.74.

Intuitive Surgical Price Performance

Shares of Intuitive Surgical stock opened at $516.31 on Wednesday. The stock has a market capitalization of $183.90 billion, a PE ratio of 83.01, a P/E/G ratio of 5.11 and a beta of 1.39. Intuitive Surgical, Inc. has a 1-year low of $254.85 and a 1-year high of $523.34. The company’s fifty day simple moving average is $489.22 and its 200-day simple moving average is $444.82.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.